Rivastigmine

CAS 123441-03-2 13 current records 2 historicalSmall Molecule

Who holds supplier records for Rivastigmine? 13 organisations hold a current record for Rivastigmine: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability (10 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (7), Sweden (1), Italy (1), Peru (1) and 2 other countries (2); not recorded for 1.

Most records are filed under another form of this substance: Rivastigmine Tartrate (19 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Rivastigmine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/rivastigmine

Reading the evidence

  • 13 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 8 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (13)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Rivastigmine. Country is the organisation's recorded country, not necessarily the manufacturing site.

India7Sweden1Italy1Peru1Germany1Slovakia1Country not recorded for 1
Need Rivastigmine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (10)

Certificates of Suitability on the EDQM register for Rivastigmine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SHODHANA LABORATORIES PRIVATE LIMITED VisakhapatnamIN
CEP 2026-204 - Rev 00
Rivastigmine, Vizag site
Oct 2026—
ERREGIERRE S.P.A. San Paolo D'ArgonIT
CEP 2025-073 - Rev 01
Rivastigmine
Aug 2026Inspected Nov 2025
Italy
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2012-304 - Rev 04
Rivastigmine
Jul 2026—
AREVIPHARMA GMBH RadebeulDE
CEP 2025-405 - Rev 00
Rivastigmine
Jul 2026Inspected Jun 2025
Germany
CAMBREX KARLSKOGA AB KarlskogaSE
R1-CEP 2014-291 - Rev 01
Rivastigmine
May 2023—
SANECA PHARMACEUTICALS A.S. HlohovecSK
R1-CEP 2015-276 - Rev 00
Rivastigmine
Jan 2023—
MSN ORGANICS PRIVATE LIMITED Bibinagar VillageIN
R1-CEP 2015-279 - Rev 00
Rivastigmine
Sept 2022—
SHODHANA LABORATORIES PRIVATE LIMITED HyderabadIN
R1-CEP 2015-236 - Rev 00
Rivastigmine
Aug 2022—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
R1-CEP 2015-039 - Rev 00
Rivastigmine
Nov 2020—
Interquim, S.A. Sant Cugat Del VallèsES
R1-CEP 2013-354 - Rev 00
Rivastigmine
Jan 2020—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Rivastigmine are no longer active. These show a past filing, not current supply.

Show all 2 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Rivastigmine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL636).

Chemical identity

IUPAC name
[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
Canonical SMILES
CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
InChIKey
XSVMFMHYUFZWBK-NSHDSACASA-N
Synonyms
ENA-713, ENA-713D, Exelon, ONO-2540, Rivastigmina, Rivastigmine, Rivastigmine 3m health care ltd, SDZ-212-713, SDZ-212713, SDZ-ENA-713, Prometax, ENA 713 free base

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Cholinesterase Inhibitor
Mechanism of action
Cholinesterase Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Rivastigmine?

13 organisations hold an active US FDA Type II Drug Master File or a CEP for Rivastigmine: MSN Organics Private Limited (India), Alembic Pharmaceuticals Limited (India), CAMBREX KARLSKOGA AB (Sweden), ERREGIERRE SPA (Italy), MATRIX PHARMACORP PRIVATE LTD (India), SHODHANA LABORATORIES LTD (India), APITORIA PHARMA PRIVATE LTD (India) and APOTEX PHARMACHEM INC, and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Rivastigmine Drug Master Files are active?

MSN Organics Private Limited (DMF 29133, 36529), Alembic Pharmaceuticals Limited (DMF 29199), CAMBREX KARLSKOGA AB (DMF 29826), ERREGIERRE SPA (DMF 25871), MATRIX PHARMACORP PRIVATE LTD (DMF 26499), SHODHANA LABORATORIES LTD (DMF 40601), APITORIA PHARMA PRIVATE LTD (DMF 29519) and APOTEX PHARMACHEM INC (DMF 29033) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Rivastigmine records mean?

2 organisations have only inactive Type II DMFs for Rivastigmine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Rivastigmine have a European Certificate of Suitability?

Yes. 9 organisations hold a valid CEP for Rivastigmine on the EDQM register, including SHODHANA LABORATORIES PRIVATE LIMITED Visakhapatnam (IN), ERREGIERRE S.P.A. San Paolo D'Argon (IT), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), AREVIPHARMA GMBH Radebeul (DE), CAMBREX KARLSKOGA AB Karlskoga (SE) and SANECA PHARMACEUTICALS A.S. Hlohovec (SK) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Rivastigmine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Rivastigmine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.